Navigating the Complexities of Access to Specialty Medications with Chelsey Lindner Shields Health Solutions

Chelsey Lindner, a pharmacist and Manager of Clinical Services at Shields Health Solutions, provides insights about the growing prevalence of oral and subcutaneous injection oncology medications, which is shifting the delivery of care from the clinic to at-home. This innovation in cancer care introduces complexities around accessing and affording these specialty drugs and requires the skills of a specialty pharmacy to support the patients and providers. In an integrated care model, there is also a growing need for attention to medication adherence and monitoring for side effects by these pharmacists.   Chelsey explains, "Shields is considered a specialty pharmacy integrator. We partner with health systems across the country to help them operate best-in-class specialty pharmacy programs. We are focused on improving patient outcomes through specialized pharmacy services and supporting the optimized use of specialty medications through navigation of access, care coordination, and comprehensive medication management. So those are three of the big services Shields offers as a company." "I would say that the number one component that these oral oncology medications offer is a level of patient convenience and maintenance of their quality of life. Because what was a cancer diagnosis 20 years ago meant they were going to have to come to the health center or be admitted to the hospital to receive their treatment. Whereas now, when a patient might be faced with a certain cancer diagnosis, they will be managing it like a chronic condition. They can stay at home, they can stay with their families. They can do all of those things that they want to do that help support that quality of life as they're going through active cancer treatment. And so with that certainly comes, I think, a level of popularity. And I think the pharmaceutical companies certainly would be incentivized to continue the research in this area and the development of these agents." #ShieldsHealthSolutions #IntegratedCareModel #SpecialtyPharmacy #CancerTreatment #MedicationAdherence shieldshealthsolutions.com Download the transcript here